Comparison of hematological parameters in mild and severe COVID-19 infected patients: A retrospective observational study
Keywords:COVID-19, hematological parameters, severity
Introduction and Aim: With the coronavirus disease 2019 (COVID-19) pandemic raging on, there is a need to identify clinical and laboratory predictors which predict progression towards severe and fatal forms of this illness. Our study aims to evaluate the ability of hematologic and biochemical biomarkers to discriminate between patients with and without severe or fatal forms of COVID-19.
Materials and Methods: A retrospective study was conducted on 200 Covid positive patients;100 with mild disease and 100 with severe disease. Medical records were reviewed to collect demographic data and results of the following blood investigations were noted at admission: Hb, Platelet count, Total and Differential leukocyte count, CRP, AST, ALT, LDH, Ferritin and D-Dimer. Comparative analysis was performed between the 2 groups.
Results: A significant difference in the basophil count (mean 2.35 and 5.92) among those with mild and severe disease respectively was noted as also with the eosinophil count (mean 6.88 and 1.79). The levels of CRP were higher in those with severe disease as compared to the mild disease group (mean 276.29 and 65.23). Ferritin levels were markedly increased severe disease patients (mean 1275.66 and 533.94). D-dimer was markedly increased in COVID-19 patients with severe disease (mean 3813.91 ng/ml) compared to those with mild disease group (mean 521.78 ng/ml).
Conclusion: Hematological and biochemical markers positively correlate to the severity of covid infection, thus highlighting their role in the early diagnosis of the disease and can act as independent markers in predicting severity and prognosis of disease.
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al.,China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20; 382(8): 727-733.
Coronavirus disease 2019 (COVID-19): current literature and status in India. [Apr;2020]
Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., et al., Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020 Apr; 20(4): 425-434.
Adhikari, S. P., Meng, S., Wu, Y. J., Mao, Y. P., Ye, R. X., Wang, Q. Z., et al., Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020 Mar 17; 9(1): 29.
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al., Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382: 1199-1207.
Novel coronavirus infected pneumonia treatment scheme—Sixth edition. National Health Commission of the People’s Republic of China. 2020.
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., et al., Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708-1720.
Li G., De Clercq, E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat Rev Drug Discov. 2020; 19(3): 149-150.
Russell, C. D., Millar, J. E., Baillie, J. K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020; 395(10223): 473-475.
Zhu, Y., Cao, X., Tao, G., Xie, W., Hu, Z., Xu, D. The lymph index:a potential hematological parameter for viral infection. Int J Infect Dis. 2013; 17(7): e490 e493493.
Rabaan, A. A., Al-Ahmed, S. H., Haque, S., Sah, R., Tiwari, R., Malik, Y.S., et al., SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Le infezioni in medicina. 2020; 28(2): 174-184.
Al-Tawfiq, J. A., Hinedi, K., Abbasi, S., Babiker, M., Sunji, A., Eltigani, M. Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus. Int J Lab Hematol. 2017; 39(3): 272-278.
Panesar, N. S. What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients? Med Hypotheses. 2008; 71(2): 298-301.
He, Z., Zhao, C., Dong, Q., Zhuang, H., Song, S., Peng, G., etal., Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis. 2005; 9(6): 323-330.
Chu, H., Zhou, J., Wong, B. H., Li, C., Chan, J. F., Cheng, Z.S., et al., Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis. 2016; 213(6): 904-914.
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., et al., Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020
Henry, B. M., de Oliveira, M. H. S., Benoit, S., Plebani, M., Lippi, G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020 Jun 25; 58: 1021-1028.
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020.
Zeng, F., Huang, Y., Guo, Y., Chen, X., Xiao, L., Deng, G.Association of inflammatory markers with the severity of COVID- 19: a meta-analysis. Int J Infect Dis. 2020; 96: 467-474.
Najim, R. H., Kadhim, S. R. Biochemical and hematological parameters as a predictor for COVID -19 infection in 65 patients diagnosed by real time –PCR in Kirkuk city. SRP. 2020; 11(5): 797-799
Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., et al., Clinical features and treatment of COVID-19 patients in Northeast Chongqing. J Med Virol 2020; 0-1.
Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y. F., Li, J., et al., Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China. Med Rxiv. 2020
Zhao, W., Zha, X., Wang, N., Li, D.Z., Li, A., Yu, S. Clinical characteristics and durations of hospitalized patients with COVID- 19 in Beijing: a retrospective cohort study. Med R. 2020; 21: 1-9.
Zhang, J. J., Dong, X., Cao, Y. Y., Yuan, Y. D., Yang, Y. B., Yan, Y. Q., et al., Clinical characteristics of 140 patients infected with SARS- CoV-2 in Wuhan, China. Allergy Eur J Allergy Clin Immunol. 2020; 1-12.
Yuan, X. H., Huang, W. L., Ye, B., Chen, C.R., Huang, R. F., Feng, Wu., et al., Changes of hematological and immunological parameters in COVID19patients. International Journal of Hematology. 2020; 112: 553-559.
How to Cite
Copyright (c) 2021 Biomedicine
This work is licensed under a Creative Commons Attribution 4.0 International License.